Detailed Mechanism Funding and Narrative

Years of mechanism: 2013 2014 2015 2016 2017

Details for Mechanism ID: 17119
Country/Region: Burundi
Year: 2016
Main Partner: FHI 360
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: USDOD
Total Funding: $300,739 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $5,314
Care: TB/HIV (HVTB) $5,813
Care: Pediatric Care and Support (PDCS) $6,664
Testing: HIV Testing and Counseling (HVCT) $58,463
Sexual Prevention: Other Sexual Prevention (HVOP) $90,288
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $23,757
Treatment: Adult Treatment (HTXS) $104,725
Treatment: Pediatric Treatment (PDTX) $5,715
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV Age/Sex: 20-24 Female 2017 1
GEND_GBV By PEP service provision (related to sexual violence services provided) 2017 2
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2017 2
GEND_GBV Number of people receiving post-GBV care 2017 2
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 64
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 40
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 2,187
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 1,016
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 3,307
HTS_TST Service Delivery Point (Facility): Inpatient 2017 246
HTS_TST Service Delivery Point (Facility): Outpatient 2017 502
HTS_TST Service Delivery Point (Facility): PMTCT 2017 2,400
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 159
HTS_TST Sum of Aggregated Age/Sex <15 2017 104
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 3,203
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 3,307
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 36
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 28
PMTCT_ART Already on ART at beginning of current pregnancy 2017 39
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 2,400
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 39
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 1
PMTCT_EID Sum of Infant Age disaggregates 2017 39
PMTCT_STAT By: Number of new positives identified 2017 41
PMTCT_STAT Number of new ANC and L&D clients 2017 5,361
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 2,400
PMTCT_STAT Sum of Positives Status disaggregates 2017 41
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 11
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 82
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 12
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 82
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 187
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 187
TB_SCREENDX [Sub-Disagg of Screen Results] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 168
TB_SCREENDX [Sub-disagg of Specimen Sent] Diagnostic Test: Other (Not Xpert) 2017 240
TB_SCREENDX [Sub-disagg of Specimen Sent] Diagnostic Test: Smear Only 2017 721
TB_SCREENDX Screen Results: Screened Positive for TB 2017 192
TB_SCREENDX Screened for TB by Age/Sex: <15 Female 2017 22
TB_SCREENDX Screened for TB by Age/Sex: <15 Male 2017 15
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 346
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 552
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 935
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 5
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 27
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 5
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 55
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 92
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 115
TX_CURR Aggregated Age/Sex: <15 Female 2017 6
TX_CURR Aggregated Age/Sex: <15 Male 2017 9
TX_CURR Aggregated Age/Sex: 15+ Female 2017 414
TX_CURR Aggregated Age/Sex: 15+ Male 2017 386
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 815
TX_CURR Sum of Aggregated Age/Sex <15 2017 15
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 800
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 815
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 68
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 68
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 136
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 136
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 815
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 570
TX_PVLS Numerator: Indication: Routine 2017 470
TX_PVLS Numerator: Indication: Targeted 2017 100
TX_PVLS_den Denominator: Indication: Routine 2017 672
TX_PVLS_den Denominator: Indication: Targeted 2017 143
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 4
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 3
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 30
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 73
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 110
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 136
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 5
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 3
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 39
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 89
Cross Cutting Budget Categories and Known Amounts Total: $75,184
Gender: Gender Based Violence (GBV) $37,592
GBV Prevention
Implementation
Capacity building
Gender: Gender Equality $37,592
Changing harmful gender norms and promoting positive gender norms
Implementation
Capacity building
Increase gender-equitable access to income and productive resources, including education
Implementation
Capacity building
Equity in HIV prevention, care, treatment and support
Implementation
Capacity building